Abstract
Atrial and ventricular arrhythmias are commonly seen with exercise stress testing (EST); these are almost always nonsustained, and the significance of those findings is, at best, modest. For patients with structurally normal hearts and combinations of isolated and repetitive ventricular ectopy, EST offers some mechanistic data and some marginal long-term prognostic data. Patients with increased ectopy during exercise or immediately post exercise deserve enhanced follow-up.
In patients with congenital heart disease, EST data, in conjunction with data regarding an individual’s hemodynamic and disease-specific risks, is sometimes helpful in assessing the patient’s overall risk profile. Comprehensive assessment of patients with atrioventricular block (AVB) and pacemakers using EST, including expired gas analysis when feasible, can help define their functional capacity and inform decision-making about programming, lead revisions, or deferring therapy. Exercise testing can also help refine both implantable cardiac defibrillator (ICD) programming and medical therapy to limit inappropriate and appropriate therapies.
Catecholaminergic polymorphic ventricular tachycardia is a specific genetic and clinical disorder that is defined by the exercise arrhythmia response. Repeated EST is one part of sequential assessment of therapy.
For arrhythmogenic cardiomyopathies, while exercise testing is part of their overall clinical and phenotypic characterization, the response to EST will generally be only part of the overall decision-making.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Flinn CJ, Wolff GS, Dick M, Campbell RM, Borkat G, Casta A, et al. Cardiac rhythm after the Mustard operation for complete transposition of the great arteries. N Engl J Med. 1984;310(25):1635–8.
Dos L, Teruel L, Ferreira IJ, Rodriguez-Larrea J, Miro L, Girona J, et al. Late outcome of Senning and Mustard procedures for correction of transposition of the great arteries. Heart. 2005;91(5):652–6.
Douard H, Labbé L, Barat JL, Broustet JP, Baudet E, Choussat A. Cardiorespiratory response to exercise after venous switch operation for transposition of the great arteries. Chest. 1997;111(1):23–9.
Fredriksen PM, Pettersen E, Thaulow E. Declining aerobic capacity of patients with arterial and atrial switch procedures. Pediatr Cardiol. 2009;30(2):166–71.
Petko M, Myung RJ, Wernovsky G, Cohen MI, Rychik J, Nicolson SC, et al. Surgical reinterventions following the Fontan procedure. Eur J Cardiothorac Surg. 2003;24(2):255–9.
Fishberger SB, Wernovsky G, Gentles TL, Gamble WJ, Gauvreau K, Burnett J, et al. Long-term outcome in patients with pacemakers following the Fontan operation. Am J Cardiol. 1996;77(10):887–9.
Attenhofer Jost CH, Connolly HM, Danielson GK, Bailey KR, Schaff HV, Shen WK, et al. Sinus venosus atrial septal defect: long-term postoperative outcome for 115 patients. Circulation. 2005;112(13):1953–8.
Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6–75.
den Dulk K, Lindemans FW, Brugada P, Smeets JL, Wellens HJ. Pacemaker syndrome with AAI rate variable pacing: importance of atrioventricular conduction properties, medication, and pacemaker programmability. Pacing Clin Electrophysiol. 1988;11(8):1226–33.
Kusumoto FM, Schoenfeld MH, Barrett C, Edgerton JR, Ellenbogen KA, Gold MR, Goldschlager NF, Hamilton RM, Joglar JA, Kim RJ, Lee R, Marine JE, McLeod CJ, Oken KR, Patton KK, Pellegrini CN, Selzman KA, Thompson A, Varosy PD. 2018. ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay. Heart Rhythm. 2018. pii: S1547-5271(18)31127-5. https://doi.org/10.1016/j.hrthm.2018.10.037.
Schüller H, Brandt J. The pacemaker syndrome: old and new causes. Clin Cardiol. 1991;14(4):336–40.
Alpert MA, Curtis JJ, Sanfelippo JF, Flaker GC, Walls JT, Mukerji V, et al. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. J Am Coll Cardiol. 1986;7(4):925–32.
Menozzi C, Brignole M, Moracchini PV, Lolli G, Bacchi M, Tesorieri MC, et al. Intrapatient comparison between chronic VVIR and DDD pacing in patients affected by high degree AV block without heart failure. Pacing Clin Electrophysiol. 1990;13(12 Pt 2):1816–22.
Hargreaves MR, Channon KM, Cripps TR, Gardner M, Ormerod OJ. Comparison of dual chamber and ventricular rate responsive pacing in patients over 75 with complete heart block. Br Heart J. 1995;74(4):397–402.
Oldroyd KG, Rae AP, Carter R, Wingate C, Cobbe SM. Double blind crossover comparison of the effects of dual chamber pacing (DDD) and ventricular rate adaptive (VVIR) pacing on neuroendocrine variables, exercise performance, and symptoms in complete heart block. Br Heart J. 1991;65(4):188–93.
Michaëlsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin. 1972;4(3):85–101.
Reybrouck T, Vanden Eynde B, Dumoulin M, Van der Hauwaert LG. Cardiorespiratory response to exercise in congenital complete atrioventricular block. Am J Cardiol. 1989;64(14):896–9.
Motonaga KS, Punn R, Axelrod DM, Ceresnak SR, Hanisch D, Kazmucha JA, et al. Diminished exercise capacity and chronotropic incompetence in pediatric patients with congenital complete heart block and chronic right ventricular pacing. Heart Rhythm. 2015;12(3):560–5.
Thambo JB, Bordachar P, Garrigue S, Lafitte S, Sanders P, Reuter S, et al. Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing. Circulation. 2004;110(25):3766–72.
Karpawich PP, Rabah R, Haas JE. Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block. Pacing Clin Electrophysiol. 1999;22(9):1372–7.
Koneru JN, Swerdlow CD, Wood MA, Ellenbogen KA. Minimizing inappropriate or “unnecessary” implantable cardioverter-defibrillator shocks: appropriate programming. Circ Arrhythm Electrophysiol. 2011;4(5):778–90.
Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006;17(1):41–6.
Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367(24):2275–83.
Draper DE, Giddins NG, McCort J, Gross GJ. Diagnostic usefulness of graded exercise testing in pediatric supraventricular tachycardia. Can J Cardiol. 2009;25(7):407–10.
Maurer MS, Shefrin EA, Fleg JL. Prevalence and prognostic significance of exercise-induced supraventricular tachycardia in apparently healthy volunteers. Am J Cardiol. 1995;75(12):788–92.
Bhat DP, Du W, Karpawich PP. Testing efficacy in determination of recurrent supraventricular tachycardia among subjectively symptomatic children following “successful” ablation. Pacing Clin Electrophysiol. 2014;37(8):1009–16.
Bunch TJ, Chandrasekaran K, Gersh BJ, Hammill SC, Hodge DO, Khan AH, et al. The prognostic significance of exercise-induced atrial arrhythmias. J Am Coll Cardiol. 2004;43(7):1236–40.
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force and the European Society of Cardiology Committee for practice guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(10):e385–484.
Crosson JE, Callans DJ, Bradley DJ, Dubin A, Epstein M, Etheridge S, et al. PACES/HRS expert consensus statement on the evaluation and management of ventricular arrhythmias in the child with a structurally normal heart. Heart Rhythm. 2014;11(9):e55–78.
Pedersen CT, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T, et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Heart Rhythm. 2014;11(10):e166–96.
Cohen MI. Frequent premature ventricular beats in healthy children: when to ignore and when to treat? Curr Opin Cardiol. 2019;34(1):65–72. https://doi.org/10.1097/HCO.0000000000000581.
Ghosh RM, Gates GJ, Walsh CA, Schiller MS, Pass RH, Ceresnak SR. The prevalence of arrhythmias, predictors for arrhythmias, and safety of exercise stress testing in children. Pediatr Cardiol. 2015;36(3):584–90.
Kim J, Kwon M, Chang J, Harris D, Gerson MC, Hwang SS, et al. Meta-analysis of prognostic implications of exercise-induced ventricular premature complexes in the general population. Am J Cardiol. 2016;118(5):725–32.
Verdile L, Maron BJ, Pelliccia A, Spataro A, Santini M, Biffi A. Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities. Heart Rhythm. 2015;12(1):78–85.
Beaufort-Krol GC, Dijkstra SS, Bink-Boelkens MT. Natural history of ventricular premature contractions in children with a structurally normal heart: does origin matter? Europace. 2008;10(8):998–1003.
Bertels RA, Harteveld LM, Filippini LH, Clur SA, Blom NA. Left ventricular dysfunction is associated with frequent premature ventricular complexes and asymptomatic ventricular tachycardia in children. Europace. 2017;19(4):617–21.
Guerrier K, Anderson JB, Czosek RJ, Mays WA, Statile C, Knilans TK, et al. Usefulness of ventricular premature complexes in asymptomatic patients ≤21 years as predictors of poor left ventricular function. Am J Cardiol. 2015;115(5):652–5.
Roggen A, Pavlovic M, Pfammatter JP. Frequency of spontaneous ventricular tachycardia in a pediatric population. Am J Cardiol. 2008;101(6):852–4.
Harris KC, Potts JE, Fournier A, Gross GJ, Kantoch MJ, Cote JM, et al. Right ventricular outflow tract tachycardia in children. J Pediatr. 2006;149(6):822–6.
Pfammatter JP, Paul T. Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. J Am Coll Cardiol. 1999;33(7):2067–72.
Barry OM, Gauvreau K, Rhodes J, Reichman JR, Bourette L, Curran T, et al. Incidence and predictors of clinically important and dangerous arrhythmias during exercise tests in pediatric and congenital heart disease patients. JACC Clin Electrophysiol. 2018;4(10):1319–27.
Bricker JT, Traweek MS, Smith RT, Moak JP, Vargo TA, Garson A Jr. Exercise-related ventricular tachycardia in children. Am Heart J. 1986;112(1):186–8.
Song MK, Baek JS, Kwon BS, Kim GB, Bae EJ, Noh CI, et al. Clinical spectrum and prognostic factors of pediatric ventricular tachycardia. Circ J. 2010;74(9):1951–8.
Morwood JG, Triedman JK, Berul CI, Khairy P, Alexander ME, Cecchin F, et al. Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease. Heart Rhythm. 2004;1(3):301–8.
Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Can J Cardiol. 2014;30(10):e1–e63.
Napolitano C, Bloise R, Memmi M, Priori SG. Clinical utility gene card for: catecholaminergic polymorphic ventricular tachycardia (CPVT). Eur J Hum Genet. 2014;22(1). https://doi.org/10.1038/ejhg.2013.55.
Napolitano C, Bloise R, Monteforte N, Priori SG. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation. 2012;125(16):2027–34.
Sumitomo N. Current topics in catecholaminergic polymorphic ventricular tachycardia. J Arrhythm. 2016;32(5):344–51.
Campuzano O, Beltran-Alvarez P, Iglesias A, Scornik F, Perez G, Brugada R. Genetics and cardiac channelopathies. Genet Med. 2010;12(5):260–7.
Hayashi M, Denjoy I, Hayashi M, Extramiana F, Maltret A, Roux-Buisson N, et al. The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands. Europace. 2012;14(9):1344–51.
Kannankeril PJ, Moore JP, Cerrone M, Priori SG, Kertesz NJ, Ro PS, et al. Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial. JAMA Cardiol. 2017;2(7):759–66.
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13):1533–41.
Perrin MJ, Angaran P, Laksman Z, Zhang H, Porepa LF, Rutberg J, et al. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2013;62(19):1772–9.
Karlsson D, Engvall J, Ando AA, Aneq MA. Exercise testing for long-term follow-up in arrhythmogenic right ventricular cardiomyopathy. J Electrocardiol. 2017;50(2):176–83.
Sequeira IB, Kirsh JA, Hamilton RM, Russell JL, Gross GJ. Utility of exercise testing in children and teenagers with arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2009;104(3):411–3.
Verrier RL, Klingenheben T, Malik M, El-Sherif N, Exner DV, Hohnloser SH, et al. Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility – consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol. 2011;58(13):1309–24.
Cheung MM, Davis AM, Cohen RJ, Wilkinson JL. T wave alternans threshold in normal children. J Cardiovasc Electrophysiol. 2001;12(4):424–7.
Cheung MM, Weintraub RG, Cohen RJ, Karl TR, Wilkinson JL, Davis AMCRJ. T wave alternans threshold late after repair of tetralogy of Fallot. J Cardiovasc Electrophysiol. 2002;13(7):657–61.
Alexander ME, Cecchin F, Huang KP, Berul CI. Microvolt t-wave alternans with exercise in pediatrics and congenital heart disease: limitations and predictive value. Pacing Clin Electrophysiol. 2006;29(7):733–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dionne, A., O’Leary, E.T., Baskar, S., Bezzerides, V.J., Alexander, M.E. (2019). Exercise Testing in the Management of Arrhythmias. In: Rhodes, J., Alexander, M., Opotowsky, A. (eds) Exercise Physiology for the Pediatric and Congenital Cardiologist. Springer, Cham. https://doi.org/10.1007/978-3-030-16818-6_32
Download citation
DOI: https://doi.org/10.1007/978-3-030-16818-6_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16817-9
Online ISBN: 978-3-030-16818-6
eBook Packages: MedicineMedicine (R0)